AMCP Market Insights Logo

Market Insights Program

Uncovering Practical Managed Care Insights for Population Management

Featured Research – Health Plan Best Practice: Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC)

A deep dive into health plan best practice recommendations for biomarker testing in the treatment of non-small cell lung cancer (NSCLC), including national health plan survey results and insights from a panel of six oncology and managed care experts.

View Best Practice Webcast

Expert Faculty

 

Ryan Haumschild, PharmD, MS, MBA

Moderator
Director of Pharmacy Services, Emory Healthcare and Winsor Cancer Institute

 

Tim Mok, PharmD, BCPS, BСОР

Hematology Oncology Pharmacy Research Analyst, Kaiser Permanente

 

Laura Bobolts, PharmD, BСОР

Senior Vice President, Clinical Strategy and Growth, OncoHealth

 

Jorge Garcia, PharmD, MS, MHA, MBA, FACHE

Assistant Vice President, System Oncology Pharmacy, Baptist Health

 

Susan Wescott, R. Ph, MBA

Senior Director of Pharmacy, Managed Care Mayo Clinic

 

Wendy Bailey, RPh, BSPharm, MSPharm, MBA

Principal, Bailey Healthcare Consulting


 

Published Disease Research

Amyotrophic Lateral Sclerosis

Delve into new research on managed care interventions to improve the quality of life of those living with ALS. 

Cancer – Antibody Drug Conjugates (ADC’s)

Explore best practices for optimizing the use of ADCs in cancer treatment that were informed by consultation with clinical and payer experts, literature review, practice guidelines, and emerging evidence.

Cancer – Chronic Lymphocytic Leukemia

Discover payer perspectives on optimizing BTK Inhibitors in CLL management, including the importance of multi-stakeholder dialogue and factors influencing patient outcomes and value-based decisions.

Cancer – Non-Small Cell Lung Cancer (NSCLC)

Delve into cutting-edge research in advancing precision medicine for NSCLC. See how managed care interventions can directly improve clinical outcomes of NSCL patients.

Diabetes – Continuous Glucose Monitoring

Uncover payer research on how to drive collaborative, evidence-based decisions to optimize the use of CGM for improving diabetes outcomes.

Food Allergy

Learn about the different pathology of food allergies and discover how payers are shaping benefit design and formulary access with emerging therapeutics in mind.

Inherited Blood Disorder

Discover a two-part series delving into disease pathology, therapeutic management for IBD, and payer considerations for optimizing outcomes and cost and risk management of new therapeutics.

Mental Health in Rare Disease

Discover how managed care strategies can effectively address the distinct mental health challenges encountered by individuals affected by rare diseases.

Wet Macular Degeneration

Discover the insights on the prevalence, treatment modalities and advancements, benefit design strategies, and collaborative payer and provider opportunities to improve the treatment of wAMD.

Diabetes (Type 1)

Learn more about Type 1 Diabetes disease management throughout the three stages.

  • Listen to the Roundtable Webinar - Coming Soon
  • Read the findings in JMCP - Coming Soon

Idiopathic Hypersomnia

Discover the impact of excessive daytime sleepiness (EDS) and idiopathic hypersomnia (IH) on quality of life, prevalence, and disease burden, along with advancements in screening, diagnosis, and treatment strategies, including payer insights and considerations for emerging therapies.

  • Listen to the Roundtable Webinar - Coming Soon
  • Read the findings in JMCP - Coming Soon

Multiple Sclerosis

Gain insights into the development and types of multiple sclerosis (MS), advancements in treatment options, and the role of guidelines and health care coverage in shaping effective MS management strategies through expert collaboration.

  • Listen to the Roundtable Webinar - Coming Soon
  • Read the findings in JMCP - Coming Soon

Retinal Disease Management

Explore opportunities for interdisciplinary Retinal Disease Management from a panel of Chief Medical and Pharmacy Officers.

  • Read the findings in JMCP - Coming Soon
  • View the Infographic - Coming Soon

Precision Oncology

Precision Oncology

Explore strategies to optimize biomarker-driven oncology decision-making by addressing barriers to testing and treatment selection, leveraging precision medicine to improve patient outcomes, and engaging diverse stakeholder perspectives to develop actionable best practices for oncology care.


 

Upcoming Disease Research

Bispecific Antibody

Bispecifics

Breast Cancer

Breast Cancer